tiprankstipranks
Advertisement
Advertisement
Alnylam initiated with a Buy at Citi
PremiumThe FlyAlnylam initiated with a Buy at Citi
17d ago
Alnylam’s New Hypertension Combo Study Could Reshape Its Long-Term Value
Premium
Company Announcements
Alnylam’s New Hypertension Combo Study Could Reshape Its Long-Term Value
21d ago
Alnylam Steps Into Obesity Drug Race With New ALN-2232 Trial
Premium
Company Announcements
Alnylam Steps Into Obesity Drug Race With New ALN-2232 Trial
21d ago
MBX Biosciences appoints Mark Soued as chief commercial officer.
PremiumThe FlyMBX Biosciences appoints Mark Soued as chief commercial officer.
28d ago
Alnylam Maintained at Buy as Strong TTR-Driven Momentum and Pipeline Progress Support Unchanged $510 Price Target
Premium
Ratings
Alnylam Maintained at Buy as Strong TTR-Driven Momentum and Pipeline Progress Support Unchanged $510 Price Target
30d ago
Alnylam price target raised to $370 from $360 at Morgan Stanley
Premium
The Fly
Alnylam price target raised to $370 from $360 at Morgan Stanley
1M ago
Myles Minter Reiterates Buy on Alnylam After Strong Beat, Reaffirmed 2026 Outlook, and Advancing TRITON Phase III Pipeline
PremiumRatingsMyles Minter Reiterates Buy on Alnylam After Strong Beat, Reaffirmed 2026 Outlook, and Advancing TRITON Phase III Pipeline
1M ago
ALNY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ALNY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Alnylam: Buy Rating Reiterated as TTR Strength and Pipeline Prospects Support Unchanged $549 Price Target
Premium
Ratings
Alnylam: Buy Rating Reiterated as TTR Strength and Pipeline Prospects Support Unchanged $549 Price Target
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100